Edition:
United Kingdom

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.91USD
19 Jan 2018
Change (% chg)

$0.06 (+1.56%)
Prev Close
$3.85
Open
$3.85
Day's High
$3.91
Day's Low
$3.84
Volume
1,200
Avg. Vol
6,911
52-wk High
$5.76
52-wk Low
$2.66

Latest Key Developments (Source: Significant Developments)

Evogene Q3 loss per share $0.20
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Evogene Ltd ::Evogene reports third quarter 2017 financial results.Q3 revenue $700,000 versus $1.5 million.Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million.Evogene Ltd qtrly loss per share $0.20​.  Full Article

Evogene Qtrly loss per share $0.18
Thursday, 11 Aug 2016 

Evogene Ltd : Evogene reports second quarter 2016 financial results .Q2 revenue $1.8 million versus $2.7 million.  Full Article

Evogene reports Q1 loss per share $0.13
Thursday, 19 May 2016 

Evogene Ltd : Qtrly loss per share $0.13 .Q1 revenue $2.0 million versus $2.7 million.  Full Article

Evogene and Marrone Bio Innovations disclose positive results in insect control
Monday, 16 May 2016 

Evogene Ltd : Evogene and Marrone Bio Innovations disclose positive results in insect control collaboration .Based on results, selected bioactive proteins are now being advanced by two companies to plant validation.  Full Article

BRIEF-Evogene Announces Positive 2nd Year Field Trial Results In Corn Bio-Stimulant Ag-Biologicals Program

* EVOGENE ANNOUNCES POSITIVE 2ND YEAR FIELD TRIAL RESULTS IN CORN BIO-STIMULANT AG-BIOLOGICALS PROGRAM Source text for Eikon: Further company coverage: